Navigation Links
David Ebersman Joins Ironwood Board of Directors
Date:9/14/2009

CAMBRIDGE, Mass., Sept. 14 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that David Ebersman has joined the Company's Board of Directors. Mr. Ebersman is the chief financial officer of Facebook. He served at Genentech from 1994-2009 in a number of senior positions, including executive vice president and chief financial officer, senior vice president of product operations, vice president of product development, and project team leader for Avastin((R)), Genentech's breakthrough cancer therapy.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081006/NEM080ALOGO )

"We are thrilled to have David join our board. He is owner-oriented, exceptionally strategic, and committed to fostering an environment with a high degree of integrity. He also brings broad industry experience that will enrich our Board deliberations," said Peter Hecht, CEO of Ironwood.

"I share the Ironwood team's passion for delivering important new medicines to patients," said Mr. Ebersman. "I am excited to contribute to Ironwood's efforts to build a great and enduring business."

Mr. Ebersman has an A.B. in economics and international relations from Brown University and is a fellow in the Henry Crown Fellowship Program.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (www.ironwoodpharma.com) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, the Company's first-in-class compound, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood has raised $306 million in private equity financing and is located in Cambridge, Massachusetts.

    Contact:
    Susan Brady
    Corporate Communications
    617.621.8304
    sbrady@ironwoodpharma.com


'/>"/>
SOURCE Ironwood Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. David Duncan Has a Prescription for American Health Care
2. Delcath Systems, Inc. Appoints David McDonald Chief Financial Officer
3. David Blumenthal and Aneesh Chopra Give Keynote Addresses at AMIAs Conference on Anticipating and Addressing Unintended Consequences of HIT and Policy
4. Allied Worlds David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium
5. Pro Quarterback David Garrard Aims to Score Big For Crohns Disease During the 2009 Football Season
6. Health Expert Dr. David Friedman Reveals Which Sweeteners Are Best
7. Dr. David Okrongly Appointed CEO of Quanterix Corporation
8. Jackson & Coker Names David Booher Vice President of Emergency Medicine Recruitment
9. Phoenix Cardiovascular Surgeon, David J. Caparrelli, M.D. Becomes Member of the Society for Vascular Surgery
10. Re-Envision Your Look: Dr. David Whiteman Suggests Breast Revision Surgery as Solution for Women Dissatisfied with Prior Procedures
11. Huntsville, Alabama Plastic Surgeon David L. Durst, MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... Dec. 8, 2016  Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...
Breaking Medicine Technology: